Home/Filings/4/0001104659-25-021871
4//SEC Filing

Puri Raj K. 4

Accession 0001104659-25-021871

CIK 0001425205other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 8:06 PM ET

Size

6.2 KB

Accession

0001104659-25-021871

Insider Transaction Report

Form 4
Period: 2025-03-05
Puri Raj K.
Chief Regulatory Officer
Transactions
  • Award

    Restricted Stock Units

    2025-03-05+117,190117,190 total
    Common stock (117,190 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

Issuer

IOVANCE BIOTHERAPEUTICS, INC.

CIK 0001425205

Entity typeother

Related Parties

1
  • filerCIK 0002046483

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 8:06 PM ET
Size
6.2 KB